PAL
Click for more information
0.00% 29.5¢ palla pharma limited

Ann: Palla Pharma Investor Presentation - FY19 Results & Outlook, page-18

  1. Alee26
    2,278 Posts.
    lightbulb Created with Sketch. 259
    clock Created with Sketch.
    30/03/20
    19:19
    Post #: 43782391
    Next few years will be ridden with nasty surprises and losses. Debt will weigh on them. No profits and another one CR in order to survive. Total laggard.
    Last edited by Alee26: 30/03/20
    PAL Price at posting: 48.0¢ Sentiment: Sell Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.